Our staff is here to support the community during these difficult times. We are safely and effectively communicating with clients by phone, email and video conference. Contact Us Today!

Latest Risperdal Case Developments: New Study, Start of Bellwether Trial, $2.2 Billion Settlement

With 900 pending Multi-District Litigation cases in Philadelphia, the first bellwether trial concerning Risperdal’s side effects started on Monday. The Nov. 3 trial (Re: Risperdal Litigation, Case No: 100300296, in the Philadelphia Court of Common Pleas) is the start of three to determine how the jury will respond. The second has been scheduled for January…

Read More

New Study Indicates Risperdal Causes Gynecomastia in Middle-Aged Men

Risperdal, an antipsychotic given to adults for schizophrenia and bipolar disorder and to children for treating autism-related irritability, has been associated with breast development in men, a condition known as gynecomastia. A 2006 study in the Journal of Clinical Psychopharmacology confirmed a link, but the research primarily focused on adolescents. As a result, the study…

Read More

Risperdal’s Side Effects: Range and Severity

Risperdal, an atypical antipsychotic approved for treatment of bipolar disorder and schizophrenia in adults and autism and bipolar disorder in children, has been the subject of multiple lawsuits at the state level. Plaintiffs claim manufacturer Johnson & Johnson never provided sufficient warning about side effects, and stated false claims concerning risks in advertising. As well,…

Read More

$650 Million Settlement Reached in MDL Pradaxa Mass Tort Claim

Starting in 2012, cases concerning anticoagulant Pradaxa sprang up rapidly at state and federal levels. Plaintiffs alleged manufacturer Boehringer Ingelheim International GmbH did not provide medical professionals and patients with sufficient information about major risks, such as excessive bleeding from mild trauma and no antidote to hemorrhaging. As of December 2013, 1,963 lawsuits had been…

Read More

Low Testosterone Lawsuit Update: New Side Effects, More Research, MDL Consolidation

Lawsuits concerning low-testosterone supplements have accelerated over the past two months, with more developments surfacing since then. Back in April, a press release from UNT Health Science Center revealed that not only are the supplements like AndroGel associated with increased cardiovascular risks, but they’re also correlated with brain cell damages in certain races. Researchers found…

Read More